Which serologic laboratory test should be ordered to evaluate suspected celiac disease in a patient with IgG antibodies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Laboratory Testing for Celiac Disease in IgA-Deficient Patients

For patients with IgA deficiency suspected of having celiac disease, order IgG-based serologic tests: specifically IgG anti-tissue transglutaminase (tTG-IgG) or IgG anti-deamidated gliadin peptide (DGP-IgG), or IgG endomysial antibody (EMA-IgG). 1, 2

Diagnostic Algorithm for IgA-Deficient Patients

When evaluating a patient with suspected celiac disease who has IgA deficiency:

Step 1: Confirm Total IgA Deficiency

  • Measure total IgA levels first
  • IgA deficiency is defined as total IgA below the lower limit of detection 1

Step 2: Order IgG-Based Celiac Serology

The following IgG tests have equivalent diagnostic utility in IgA deficiency:

  • IgG anti-tissue transglutaminase (tTG-IgG)
  • IgG anti-deamidated gliadin peptide (DGP-IgG)
  • IgG endomysial antibody (EMA-IgG)

1, 2

Critical Distinction

IgG isotype testing for tTG antibody is NOT specific in patients WITHOUT IgA deficiency 2. This is a common pitfall—IgG-based tests should only be used when IgA deficiency is documented.

Evidence Quality and Rationale

The 2021 AGA guidelines on seronegative enteropathies 1 and the 2019 AGA clinical practice update 2 both explicitly state that patients with total IgA levels below detection limits who test positive for IgG-based celiac antibodies should be considered to have celiac disease with selective IgA deficiency rather than seronegative celiac disease.

Research evidence supports this approach, with a 2003 study demonstrating that IgG anti-tTG had 98.7% sensitivity and 98.6% specificity in IgA-deficient celiac patients 3. The correlation between IgG anti-tTG and IgG EMA was high (r=0.91), and both antibody levels decreased significantly with gluten-free diet treatment.

Important Caveats

  • All three IgG-based tests (tTG-IgG, DGP-IgG, EMA-IgG) have very similar diagnostic accuracy in IgA deficiency 4
  • The high prevalence of celiac antibodies among asymptomatic IgA-deficient individuals (9.8% in one study) indicates that all IgA-deficient persons should be evaluated for celiac disease 3
  • Patients must be consuming gluten at the time of testing—gluten avoidance reduces test sensitivity 2
  • Duodenal biopsy remains necessary for diagnostic confirmation in adults, even with positive IgG serology 1

References

4
Research

The role of serology in the diagnosis of coeliac disease.

Gastroenterology and hepatology from bed to bench, 2023

Related Questions

Should I obtain a celiac disease screen (serum IgA tissue‑transglutaminase antibodies and total serum IgA) for a 6‑year‑old child with chronic abdominal pain and ultrasound showing tiny biliary sludge?
In a patient with recurrent oral ulcers and epigastric burning, how should I order and interpret tissue transglutaminase (tTG) antibody testing, including IgA status and current gluten intake?
Why is IgA anti‑tissue transglutaminase (tTG‑IgA) with total IgA the preferred initial test for celiac disease, and what IgG‑based test should be used if the patient is IgA deficient?
Are tTG and gliadin alternative names for the same test?
What do tissue transglutaminase IgG (8) and tissue transglutaminase IgA (<2) results indicate?
Which laboratory test is appropriate for this patient?
What is the recommended management for empyema, including antibiotics, chest tube drainage, fibrinolytic therapy, and surgical intervention?
For a patient on mechanical ventilation who continues to have elevated PaCO₂, how should ventilator settings and overall management be adjusted to reduce hypercapnia?
In an adult male who took daily tadalafil (Cialis) 5 mg for two weeks, then a single 10 mg dose, followed by two 30 mg doses of sildenafil (Viagra) on the same night and now presents with a month‑long persistent partially rigid, discolored penis, numbness, urinary and bowel symptoms, what is the expected healing timeline and is continued penile discoloration normal before full recovery?
I am taking daily tadalafil (Cialis) with an extra 10 mg dose and two 30 mg sildenafil (Viagra) tablets on the same night, and now experience partial erections that are firm at the base, bent, shortened, with a soft glans, especially when cuddling with a relative. What is causing these abnormal erections?
In a 19-year-old man presenting with sore throat, fever, anterior cervical lymphadenopathy, and tonsillar exudate, which of the following statements is incorrect?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.